Barely Significant
← all excerpts

Randomized, Placebo-Controlled Trial on the Renal and Systemic Hemodynamic Effects of Empagliflozin.

Kidney Int Rep · 2025 · PMC11725969 · PMID 39810756

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)
Although uACR was reduced by 50% in the DM2 group and 20% in the CKD group, these changes did not reach statistical significance ( P = 0.07 and P = 0.24, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.